Professor François H Nosten
Contact information
Podcast interview
Between research and humanitarian

Healthcare and research at the Thai-Burma border: Combining healthcare and research allow Professor Nosten to implement a new treatment regimen as soon as the results from clinical trials are available, which is beneficial to patients and highly rewarding for researchers.
François Nosten
Professor in Tropical Medicine
- Director of the Shoklo Malaria Research Unit, Thailand
Shoklo Malaria research Unit
Dr Nosten’s work concentrates on uncomplicated malaria and he has conducted the largest ever drug trials in malaria in an area which has the world’s most drug-resistant parasites, including a detailed study of the SPf66 malaria vaccine. Recent studies have concentrated on the efficacy and effectiveness of combination anti malarial therapy. Dr Nosten has also investigated malaria prophylaxis and antimalarial treatment in pregnancy and the identification of thiamine deficiency (beri-beri) as a major cause of infant mortality amongst Karen refugees.
Recent publications
Parasitological efficacy of seasonal malaria chemoprevention in Nampula, northern Mozambique
Journal article
Bonnington C. et al, (2026), Transactions of The Royal Society of Tropical Medicine and Hygiene, 120, 258 - 267
Transplacental Transfer of Lumefantrine, Mefloquine, and Piperaquine: A Comparison of Concentrations in Mothers, Neonates, and Cord Blood
Journal article
Saito M. et al, (2026), Clinical Infectious Diseases, 82, e165 - e173
Cohort Profile: the SMRU Refugee and Migrant Pregnancy Study in Western Thailand and Eastern Myanmar
Journal article
McGready R. et al, (2026), Wellcome Open Research, 11, 21 - 21
Engagement with migrant communities at the Thai-Myanmar border: Lessons learnt from a community advisory board
Journal article
Khirikoekkong N. et al, (2026), Research Ethics, 22, 198 - 207
Plasmodium vivax Malaria Relapse Risk Depends on Transmission Intensity: Evidence From a Longitudinal Study in Northwest Thailand
Journal article
Chu CS. et al, (2025), Open Forum Infectious Diseases, 13